...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: something. anything.
3
Feb 28, 2020 02:21PM
5
Feb 28, 2020 02:37PM
4
Mar 03, 2020 10:46AM

"Does anyone recall if fthey have attended ASCO in the recent past?"

They attended last year, as indicated on their events page. I don't see anything about 2020 on their events page. Got a link for what you are seeing?

BDAZ

1
Mar 04, 2020 07:47AM
Share
New Message
Please login to post a reply